Paper2425443
Interferons: current status and future directions of this prototypic biological.
Smalley RV and 1 other. Springer Semin Immunopathol, 1986. Cited by 22 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Interferons: current status and future directions of this prototypic biological. Papers, record 2425443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2425443
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Adjuvants, Immunologic | |
| Antibodies, Monoclonal | |
| Breast Neoplasms | |
| Clinical Trials as Topic | |
| Drug Therapy | |
| Female | |
| Humans | |
| Interferon Type I | |
| Interferon-gamma | |
| Killer Cells, Natural | |
| Leukemia, Hairy Cell | |
| Leukemia, Myeloid | |
| Lymphoma | |
| Male | |
| Molecular Weight | |
| Recombinant Proteins | |
| Sarcoma, Kaposi |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,891,642 | Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6891642 | PubMed |
| 2 | 6,168,319 | Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. | Blood | 1981 | https://conductscience.org/library/papers/6168319 | PubMed |
| 3 | 6,091,102 | Site-specific mutagenesis of the human fibroblast interferon gene. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6091102 | PubMed |
| 4 | 6,692,412 | Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system. | Cancer Res | 1984 | https://conductscience.org/library/papers/6692412 | PubMed |
| 5 | 6,179,076 | Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6179076 | PubMed |
| 6 | 6,715,911 | Radiosensitization of human bronchogenic carcinoma cells by interferon beta. | J Interferon Res | 1984 | https://conductscience.org/library/papers/6715911 | PubMed |
| 7 | 6,470,751 | Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6470751 | PubMed |
| 8 | 6,198,954 | Interferon as a modifier of estrogen receptors. | Ann Clin Lab Sci | 1984 | https://conductscience.org/library/papers/6198954 | PubMed |
| 9 | 6,159,812 | Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. | Ann Intern Med | 1980 | https://conductscience.org/library/papers/6159812 | PubMed |
| 10 | 6,744,259 | Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744259 | PubMed |
| 11 | 6,861,260 | Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6861260 | PubMed |
| 12 | 7,160,583 | Effects of human fibroblast interferon on human tumors transplanted into nude mice: sensitivity of human tumors to interferon. | Gan | 1982 | https://conductscience.org/library/papers/7160583 | PubMed |
| 13 | 6,835,320 | Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6835320 | PubMed |
| 14 | 6,548,079 | Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma. | Am J Med | 1984 | https://conductscience.org/library/papers/6548079 | PubMed |
| 15 | 29,356 | Preparation of human leukocyte interferon for clinical use. | Tex Rep Biol Med | 1977 | https://conductscience.org/library/papers/29356 | PubMed |
| 16 | 6,498,762 | Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma. | Cancer | 1984 | https://conductscience.org/library/papers/6498762 | PubMed |
| 17 | 6,686,847 | Effects of cloned human leukocyte interferons in the human tumor stem cell assay. | J Clin Oncol | 1983 | https://conductscience.org/library/papers/6686847 | PubMed |
| 18 | 6,684,502 | Enhancement of actinomycin D- and cis-diamminedichloroplatinum(II)-induced killing of human fibroblasts by human beta-interferon. | Cancer Res | 1983 | https://conductscience.org/library/papers/6684502 | PubMed |
| 19 | 6,589,637 | A species of human alpha interferon that lacks the ability to boost human natural killer activity. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6589637 | PubMed |
| 20 | 6,577,942 | Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6577942 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,510,292 | Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells. | J Cancer Res Clin Oncol | 1994 | https://conductscience.org/library/papers/7510292 | PubMed |
| 3,533,606 | Immunogenetics. | Experientia | 1986 | https://conductscience.org/library/papers/3533606 | PubMed |
| 1,760,815 | Biochemical and immunological responses of hairy cell leukemia patients to interferon beta. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1760815 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2425443
GET https://conductscience.org/api/papers/v1/2425443/references?page=2